# FDA Inspection 1095285 - UBI Pharma, Inc. - June 20, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/ubi-pharma-inc/df85d9ee-ae80-49ae-b430-d7efd7d8a70d
Source feed: FDA_Inspections

> FDA Inspection 1095285 for UBI Pharma, Inc. on June 20, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095285
- Company Name: UBI Pharma, Inc.
- Inspection Date: 2019-06-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290852 - 2025-10-14](https://www.globalkeysolutions.net/records/fda_inspections/ubi-pharma-inc/d208ea55-c9e0-4165-a330-d88113d642ae)
- [FDA Inspection 1207579 - 2023-06-06](https://www.globalkeysolutions.net/records/fda_inspections/ubi-pharma-inc/4fca95a0-fdff-4807-a9cd-7a34d9f0f068)
- [FDA Inspection 890363 - 2014-07-18](https://www.globalkeysolutions.net/records/fda_inspections/ubi-pharma-inc/02e9f60f-ada5-408e-b854-e87220aa675b)
- [FDA Inspection 794206 - 2012-08-06](https://www.globalkeysolutions.net/records/fda_inspections/ubi-pharma-inc/dca91f74-44fa-43d7-8d05-fa0804becbb6)

Company: https://www.globalkeysolutions.net/companies/ubi-pharma-inc/c7dfbd38-5fae-4a48-b959-a3abae44f320

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c